Latest News and Press Releases

Dermatology expert Dr. Hannah Pederson answers why people experience acne breakouts even when following what seems like a healthy skincare routine.

White Oak, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry,...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate,...

Day One today announced the release of preliminary 2025 OJEMDA™ net product revenue and provides 2026 net product revenue guidance

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million to support Teva’s anti-IL-15 candidate...

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program...

MIAMI, FL, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Why Consumers Are Researching Ozempatch Ingredients in 2026 OzemPatches, also promoted under the name Rejuvacare Ozempatch, is a topical herbal...

미국 노스캐롤라이나주 롤리, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Attindas Hygiene Partners는 이탈리아의 Società Italiana Lavorazione Cellulosa(SILC S.p.A.)를 인수하며 성장 전략의 중요한 진전을 이뤘다고 이날 밝혔다. Attindas는 SILC와 주식매매계약(SPA)을...

ノースカロライナ州ローリー発, Jan. 10, 2026 (GLOBE NEWSWIRE) -- アティンダス・ハイジーン・パートナーズ (Attindas Hygiene Partners) は本日、ソシエタ・イタリアーナ・ラヴォラツィオーネ・チェルローザ (Società Italiana Lavorazione Cellulosa、SILC S.p.A.)...